NCT05163028
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05163028
Title A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors HUYABIO International, LLC.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
California Cancer Associates for Research and Excellence, Inc. (cCare) Encinitas California 92024 United States Details
Providence Medical Foundation Fullerton California 92835 United States Details
California Cancer Associates for Research and Excellence, Inc. (cCare) San Marcos California 92069 United States Details
Sarcoma Oncology Santa Monica California 90403 United States Details
UCLA Hematology/Oncology Santa Monica California 90404 United States Details
Orlando Health, Inc. Orlando Florida 32806 United States Details
BRCR Medical Center Plantation Florida 33322 United States Details
Gabrail Cancer Center Canton Ohio 44718 United States Details
Texas Oncology - Tyler Tyler Texas 75702 United States Details
Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
Pan American Center for Oncology Trials (PanOncology Trials) Rio Piedras Puerto Rico 00935 Puerto Rico Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field